Nigel Sheinwald
CIK 1642391 · View on SEC EDGAR ↗
Insider
First SEC filing: May 15, 2015 · Latest: May 15, 2015
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 28 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 15, 2023 | IVZ | A | 12,820 | — | — | 69,173 Direct | +22.75% | Acquired | (price as of 2026-08-19) |
| May 15, 2022 | IVZ | A | 10,930 | — | — | 56,353 Direct | +24.06% | Acquired | (price as of 2026-08-19) |
| May 15, 2021 | IVZ | A | 5,807 | — | — | 45,423 Direct | +14.66% | Acquired | (price as of 2026-08-19) |
| April 29, 2021 | IVZ | A | 1,311 | — | — | 39,616 Direct | +3.42% | Acquired | (price as of 2026-08-19) |
| Jan. 27, 2021 | IVZ | A | 1,744 | — | — | 38,305 Direct | +4.77% | Acquired | (price as of 2026-08-19) |
| Oct. 28, 2020 | IVZ | A | 2,719 | — | — | 36,561 Direct | +8.03% | Acquired | (price as of 2026-08-19) |
| July 29, 2020 | IVZ | A | 3,419 | — | — | 33,842 Direct | +11.24% | Acquired | (price as of 2026-08-19) |
| April 24, 2020 | IVZ | A | 4,647 | — | — | 30,423 Direct | +18.03% | Acquired | (price as of 2026-08-19) |
| Jan. 30, 2020 | IVZ | A | 2,056 | — | — | 25,776 Direct | +8.67% | Acquired | (price as of 2026-08-19) |
| Oct. 25, 2019 | IVZ | A | 2,126 | — | — | 23,720 Direct | +9.85% | Acquired | (price as of 2026-08-19) |
| July 26, 2019 | IVZ | A | 1,848 | — | — | 21,594 Direct | +9.36% | Acquired | (price as of 2026-08-19) |
| April 26, 2019 | IVZ | A | 1,665 | — | — | 19,746 Direct | +9.21% | Acquired | (price as of 2026-08-19) |
| Jan. 31, 2019 | IVZ | A | 1,989 | — | — | 18,081 Direct | +12.36% | Acquired | (price as of 2026-08-19) |
| Jan. 31, 2019 | IVZ | A | 1,989 | — | — | 18,081 Direct | +12.36% | Acquired | (price as of 2026-08-19) |
| Oct. 19, 2018 | IVZ | A | 1,649 | — | — | 16,092 Direct | +11.42% | Acquired | (price as of 2026-08-19) |
| July 27, 2018 | IVZ | A | 1,395 | — | — | 14,443 Direct | +10.69% | Acquired | (price as of 2026-08-19) |
| April 27, 2018 | IVZ | A | 1,225 | — | — | 13,048 Direct | +10.36% | Acquired | (price as of 2026-08-19) |
| Feb. 1, 2018 | IVZ | A | 1,006 | — | — | 11,823 Direct | +9.30% | Acquired | (price as of 2026-08-19) |
| Oct. 26, 2017 | IVZ | A | 982 | — | — | 10,817 Direct | +9.98% | Acquired | (price as of 2026-08-19) |
| July 28, 2017 | IVZ | A | 1,055 | — | — | 9,835 Direct | +12.02% | Acquired | (price as of 2026-08-19) |
| April 28, 2017 | IVZ | A | 1,100 | — | — | 8,780 Direct | +14.32% | Acquired | (price as of 2026-08-19) |
| Jan. 27, 2017 | IVZ | A | 1,228 | — | — | 7,680 Direct | +19.03% | Acquired | (price as of 2026-08-19) |
| Oct. 28, 2016 | IVZ | A | 1,270 | — | — | 6,452 Direct | +24.51% | Acquired | (price as of 2026-08-19) |
| July 29, 2016 | IVZ | A | 1,242 | — | — | 5,182 Direct | +31.52% | Acquired | (price as of 2026-08-19) |
| April 29, 2016 | IVZ | A | 1,168 | — | — | 3,940 Direct | +42.14% | Acquired | (price as of 2026-08-19) |
| Jan. 29, 2016 | IVZ | A | 1,211 | — | — | 2,772 Direct | +77.58% | Acquired | (price as of 2026-08-19) |
| Oct. 30, 2015 | IVZ | A | 1,092 | — | — | 1,561 Direct | +232.84% | Acquired | (price as of 2026-08-19) |
| July 31, 2015 | IVZ | A | 469 | — | — | 469 Direct | — | Acquired | (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| May 15, 2015 | IVZ | Common Shares | 0 | Direct |